Oman Carotid Artery Stents Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Oman carotid artery stents market, valued at USD 7 Mn, grows due to increasing cardiovascular burden, geriatric population, and minimally invasive procedures.

Region:Middle East

Author(s):Shubham

Product Code:KRAD6638

Pages:81

Published On:December 2025

About the Report

Base Year 2024

Oman Carotid Artery Stents Market Overview

  • The Oman Carotid Artery Stents Market is valued at USD 7 million, based on a five-year historical analysis and benchmarking against the global carotid artery stents market size and typical Middle East country shares. This growth is primarily driven by the increasing prevalence of carotid artery disease as part of the broader cardiovascular disease burden in Oman, the rising incidence of stroke, advancements in stent technology (including improved self-expanding and drug-eluting designs), and growing awareness and adoption of minimally invasive carotid artery stenting among healthcare professionals and patients.
  • Muscat, the capital city, along with Dhofar and Al Batinah regions, dominate the market due to their advanced healthcare infrastructure and the presence of specialized medical facilities. These areas host most of the tertiary and referral centers where carotid endarterectomy and carotid artery stenting are performed and have benefited from sustained government investment in hospitals, catheterization laboratories, and cardiovascular services, which has improved access to carotid artery interventions.
  • In 2023, the Omani government strengthened its medical device oversight through the Medical Devices Regulation issued by the Ministry of Health under Ministerial Decision No. 36/2023, which requires that implantable cardiovascular devices, including carotid artery stents, used in public healthcare facilities be registered with the Directorate General of Pharmaceutical Affairs and Drug Control, comply with recognized international standards (such as CE marking or equivalent), and be procured only from licensed suppliers, thereby enhancing patient safety and the quality of medical devices used in the country.
Oman Carotid Artery Stents Market Size

Oman Carotid Artery Stents Market Segmentation

By Type (Mode of Delivery):The market is segmented into various types of carotid artery stents, including self-expanding, balloon-expandable, drug-eluting, and bioabsorbable stents. At a global level, balloon-expandable stents account for a larger revenue share, while self-expanding carotid stents are increasingly preferred in complex and tortuous anatomies due to their flexibility and ability to better conform to the vessel wall. In Oman, self-expanding carotid stents are widely used in routine carotid stenting practice because of their ease of deployment and adaptability to the arterial anatomy, which makes them a preferred choice for many vascular surgeons and interventional cardiologists, especially in high?risk or anatomically challenging lesions. The increasing adoption of these stents is driven by clinical evidence supporting their effectiveness in maintaining luminal patency, reducing the risk of restenosis, and improving long-term neurological outcomes in appropriately selected patients.

Oman Carotid Artery Stents Market segmentation by Type (Mode of Delivery).

By End-User:The end-user segmentation includes tertiary care hospitals, cardiac and vascular specialty centers, government & teaching hospitals, and private multispecialty hospitals and clinics. In line with broader carotid stent utilization patterns, tertiary care and large referral hospitals account for the majority of carotid artery stenting procedures because they host catheterization laboratories, hybrid operating rooms, and multidisciplinary stroke and vascular teams required for these complex interventions. The increasing number of high?risk patients being referred to these centers for carotid revascularization, coupled with the availability of advanced imaging, neuroprotection devices, and postoperative intensive care, is a significant factor contributing to their market leadership.

Oman Carotid Artery Stents Market segmentation by End-User.

Oman Carotid Artery Stents Market Competitive Landscape

The Oman Carotid Artery Stents Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Johnson & Johnson (via Cordis legacy carotid portfolio), Cook Medical LLC, Cardinal Health, Inc., Stryker Corporation, W. L. Gore & Associates, Inc. (Gore Medical), Merit Medical Systems, Inc., Koninklijke Philips N.V. (Philips Healthcare), Siemens Healthineers AG, Edwards Lifesciences Corporation, Asahi Intecc Co., Ltd. contribute to innovation, geographic expansion, and service delivery in this space.

Medtronic plc

1949

Dublin, Ireland

Boston Scientific Corporation

1979

Marlborough, Massachusetts, USA

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Terumo Corporation

1921

Tokyo, Japan

B. Braun Melsungen AG

1839

Melsungen, Germany

Company

Establishment Year

Headquarters

Group size (global revenue tier: large, medium, small)

Carotid stent segment revenue and 3–5 year CAGR (global / Middle East)

Installed base and procedure volume in Oman (annual carotid stent cases supported)

Oman market share and penetration across key hospitals

Average selling price band and discounting to major accounts

Product portfolio breadth (number of carotid stent SKUs and generations)

Oman Carotid Artery Stents Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Carotid Artery Diseases:The prevalence of carotid artery diseases in Oman is rising, with approximately 15,000 new cases reported annually. This increase is attributed to lifestyle changes and an aging population. According to the World Health Organization, cardiovascular diseases account for 30% of all deaths in Oman, highlighting the urgent need for effective treatment options like carotid artery stents. This growing patient base drives demand for advanced stenting solutions.
  • Advancements in Stent Technology:The stent technology landscape is evolving rapidly, with innovations such as drug-eluting stents and bioresorbable stents gaining traction. In future, the global market for advanced stent technologies is projected to reach $5.5 billion, reflecting a significant investment in research and development. These advancements enhance patient outcomes and reduce complications, making stenting a more attractive option for both patients and healthcare providers in Oman.
  • Rising Geriatric Population:Oman’s geriatric population is expected to reach 1.2 million in future, representing 15% of the total population. This demographic shift is significant as older adults are more susceptible to carotid artery diseases. The government’s focus on improving healthcare services for the elderly, including specialized treatments, is likely to increase the demand for carotid artery stents, thereby driving market growth in the region.

Market Challenges

  • High Cost of Stent Procedures:The average cost of carotid artery stenting procedures in Oman can exceed OMR 2,800, which poses a financial burden on patients and healthcare systems. With a per capita income of approximately OMR 22,000, many patients may find these costs prohibitive. This financial barrier can limit access to necessary treatments, thereby hindering market growth and patient outcomes in the region.
  • Limited Awareness Among Patients:Awareness of carotid artery diseases and available treatment options remains low among the Omani population. A recent health survey indicated that only 30% of respondents were aware of carotid artery stenting as a treatment option. This lack of knowledge can lead to delayed diagnoses and treatments, ultimately affecting the market's growth potential and the overall health of the population.

Oman Carotid Artery Stents Market Future Outlook

The Oman Carotid Artery Stents Market is poised for significant growth, driven by technological advancements and an increasing patient population. As healthcare infrastructure improves, more patients will gain access to innovative treatments. Additionally, the integration of digital health technologies will enhance patient monitoring and post-operative care. These trends indicate a shift towards more personalized and efficient healthcare solutions, which will likely shape the future landscape of carotid artery treatments in Oman.

Market Opportunities

  • Expansion of Healthcare Infrastructure:The Omani government is investing over OMR 1.2 billion in healthcare infrastructure in future. This investment will enhance access to advanced medical facilities and technologies, creating opportunities for the adoption of carotid artery stents and improving patient outcomes across the nation.
  • Increasing Investment in Medical Technology:With a projected increase of 12% in healthcare spending in Oman, investments in medical technology are expected to rise significantly. This trend will facilitate the introduction of innovative stent solutions, thereby expanding treatment options and improving the overall quality of care for patients with carotid artery diseases.

Scope of the Report

SegmentSub-Segments
By Type (Mode of Delivery)

Self-expanding carotid stents

Balloon-expandable carotid stents

Drug-eluting carotid stents

Bioabsorbable / biodegradable carotid stents

By End-User

Tertiary care hospitals

Cardiac and vascular specialty centers

Government & teaching hospitals

Private multispecialty hospitals and clinics

By Material

Nitinol (nickel-titanium alloy)

Cobalt-chromium alloys

Stainless steel

Polymer-based and hybrid materials

By Coating / Technology

Bare-metal carotid stents

Drug-eluting / drug-coated carotid stents

Bioabsorbable / bioresorbable scaffold stents

Embolic protection–integrated systems

By Distribution Channel

Direct tenders to hospitals and health ministries

Local distributors and agents

Group purchasing organizations (GPOs)

Others (regional wholesalers, importers)

By Region

Muscat Governorate

Dhofar (including Salalah)

Al Batinah (including Sohar)

Other governorates (interior & northern regions)

By Patient Demographics / Risk Profile

Age group (45–64 years, 65+ years)

Gender (Male, Female)

Presence of comorbidities (Diabetes, Hypertension, Dyslipidemia, Smoking)

Symptomatic vs. asymptomatic carotid artery disease

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Oman Medical Specialty Board)

Manufacturers and Producers of Carotid Artery Stents

Distributors and Wholesalers of Medical Devices

Healthcare Providers and Hospitals

Medical Device Regulatory Authorities

Health Insurance Companies

Industry Associations and Trade Organizations

Players Mentioned in the Report:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Terumo Corporation

B. Braun Melsungen AG

Johnson & Johnson (via Cordis legacy carotid portfolio)

Cook Medical LLC

Cardinal Health, Inc.

Stryker Corporation

W. L. Gore & Associates, Inc. (Gore Medical)

Merit Medical Systems, Inc.

Koninklijke Philips N.V. (Philips Healthcare)

Siemens Healthineers AG

Edwards Lifesciences Corporation

Asahi Intecc Co., Ltd.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Oman Carotid Artery Stents Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Oman Carotid Artery Stents Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Oman Carotid Artery Stents Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of carotid artery diseases
3.1.2 Advancements in stent technology
3.1.3 Rising geriatric population
3.1.4 Growing healthcare expenditure

3.2 Market Challenges

3.2.1 High cost of stent procedures
3.2.2 Limited awareness among patients
3.2.3 Stringent regulatory requirements
3.2.4 Competition from alternative treatments

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Increasing investment in medical technology
3.3.3 Collaborations with healthcare providers
3.3.4 Rising demand for minimally invasive procedures

3.4 Market Trends

3.4.1 Shift towards personalized medicine
3.4.2 Integration of digital health technologies
3.4.3 Focus on patient-centric care
3.4.4 Growth of telemedicine in post-operative care

3.5 Government Regulation

3.5.1 Approval processes for new stent technologies
3.5.2 Guidelines for clinical practices
3.5.3 Reimbursement policies for stent procedures
3.5.4 Quality control standards for medical devices

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Oman Carotid Artery Stents Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Oman Carotid Artery Stents Market Segmentation

8.1 By Type (Mode of Delivery)

8.1.1 Self-expanding carotid stents
8.1.2 Balloon-expandable carotid stents
8.1.3 Drug-eluting carotid stents
8.1.4 Bioabsorbable / biodegradable carotid stents

8.2 By End-User

8.2.1 Tertiary care hospitals
8.2.2 Cardiac and vascular specialty centers
8.2.3 Government & teaching hospitals
8.2.4 Private multispecialty hospitals and clinics

8.3 By Material

8.3.1 Nitinol (nickel-titanium alloy)
8.3.2 Cobalt-chromium alloys
8.3.3 Stainless steel
8.3.4 Polymer-based and hybrid materials

8.4 By Coating / Technology

8.4.1 Bare-metal carotid stents
8.4.2 Drug-eluting / drug-coated carotid stents
8.4.3 Bioabsorbable / bioresorbable scaffold stents
8.4.4 Embolic protection–integrated systems

8.5 By Distribution Channel

8.5.1 Direct tenders to hospitals and health ministries
8.5.2 Local distributors and agents
8.5.3 Group purchasing organizations (GPOs)
8.5.4 Others (regional wholesalers, importers)

8.6 By Region

8.6.1 Muscat Governorate
8.6.2 Dhofar (including Salalah)
8.6.3 Al Batinah (including Sohar)
8.6.4 Other governorates (interior & northern regions)

8.7 By Patient Demographics / Risk Profile

8.7.1 Age group (45–64 years, 65+ years)
8.7.2 Gender (Male, Female)
8.7.3 Presence of comorbidities (Diabetes, Hypertension, Dyslipidemia, Smoking)
8.7.4 Symptomatic vs. asymptomatic carotid artery disease

9. Oman Carotid Artery Stents Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company presence in Oman (local registration and product approvals)
9.2.2 Group size (global revenue tier: large, medium, small)
9.2.3 Carotid stent segment revenue and 3–5 year CAGR (global / Middle East)
9.2.4 Installed base and procedure volume in Oman (annual carotid stent cases supported)
9.2.5 Oman market share and penetration across key hospitals
9.2.6 Average selling price band and discounting to major accounts
9.2.7 Product portfolio breadth (number of carotid stent SKUs and generations)
9.2.8 Regulatory and tender performance (MOH tender wins, contract duration)
9.2.9 Distribution strength (number of active distributors / coverage across governorates)
9.2.10 Clinical evidence and KOL engagement (registries, publications, training programs)
9.2.11 Service and support KPIs (delivery lead time, complaint resolution time)
9.2.12 Localization efforts (pricing adaptation, local training, Arabic materials)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Medtronic plc
9.5.2 Boston Scientific Corporation
9.5.3 Abbott Laboratories
9.5.4 Terumo Corporation
9.5.5 B. Braun Melsungen AG
9.5.6 Johnson & Johnson (via Cordis legacy carotid portfolio)
9.5.7 Cook Medical LLC
9.5.8 Cardinal Health, Inc.
9.5.9 Stryker Corporation
9.5.10 W. L. Gore & Associates, Inc. (Gore Medical)
9.5.11 Merit Medical Systems, Inc.
9.5.12 Koninklijke Philips N.V. (Philips Healthcare)
9.5.13 Siemens Healthineers AG
9.5.14 Edwards Lifesciences Corporation
9.5.15 Asahi Intecc Co., Ltd.

10. Oman Carotid Artery Stents Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget allocation for medical devices
10.1.2 Decision-making processes
10.1.3 Supplier selection criteria
10.1.4 Contract management practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare facilities
10.2.2 Funding for medical technology
10.2.3 Partnerships with private sector
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to advanced medical technologies
10.3.2 Cost of treatment
10.3.3 Availability of trained professionals
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness of carotid artery stenting
10.4.2 Training programs for healthcare providers
10.4.3 Patient education initiatives
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Evaluation of treatment outcomes
10.5.2 Cost-effectiveness analysis
10.5.3 Expansion into new patient segments
10.5.4 Others

11. Oman Carotid Artery Stents Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Value proposition development

1.3 Revenue model exploration

1.4 Customer segmentation analysis

1.5 Competitive landscape assessment

1.6 Key partnerships identification

1.7 Operational framework design


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs

2.3 Target audience definition

2.4 Communication channels selection

2.5 Marketing budget allocation

2.6 Performance metrics establishment

2.7 Feedback mechanisms implementation


3. Distribution Plan

3.1 Urban retail strategies

3.2 Rural NGO tie-ups

3.3 Online distribution channels

3.4 Logistics and supply chain management

3.5 Inventory management practices

3.6 Partnership with distributors

3.7 Performance tracking


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands analysis

4.3 Competitor pricing strategies

4.4 Customer willingness to pay

4.5 Price elasticity assessment

4.6 Discounting strategies

4.7 Value-based pricing models


5. Unmet Demand & Latent Needs

5.1 Category gaps identification

5.2 Consumer segments analysis

5.3 Emerging trends exploration

5.4 Customer feedback analysis

5.5 Market research findings

5.6 Product development opportunities

5.7 Future demand forecasting


6. Customer Relationship

6.1 Loyalty programs design

6.2 After-sales service strategies

6.3 Customer engagement initiatives

6.4 Feedback collection methods

6.5 Relationship management tools

6.6 Customer satisfaction measurement

6.7 Retention strategies


7. Value Proposition

7.1 Sustainability initiatives

7.2 Integrated supply chains

7.3 Unique selling points

7.4 Customer benefits articulation

7.5 Competitive advantages

7.6 Market positioning

7.7 Brand differentiation


8. Key Activities

8.1 Regulatory compliance

8.2 Branding efforts

8.3 Distribution setup

8.4 Marketing campaigns

8.5 Training and development

8.6 Performance monitoring

8.7 Stakeholder engagement


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix considerations
9.1.2 Pricing band analysis
9.1.3 Packaging strategies

9.2 Export Entry Strategy

9.2.1 Target countries selection
9.2.2 Compliance roadmap development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield investments

10.3 Mergers & Acquisitions

10.4 Distributor Model

10.5 Risk assessment

10.6 Control considerations

10.7 Partnership evaluation


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines for market entry

11.3 Budget allocation

11.4 Resource planning

11.5 Financial projections

11.6 Funding sources

11.7 Milestone tracking


12. Control vs Risk Trade-Off

12.1 Ownership considerations

12.2 Partnership dynamics

12.3 Risk management strategies

12.4 Control mechanisms

12.5 Decision-making processes

12.6 Performance evaluation

12.7 Exit strategies


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability

13.3 Profit margin assessment

13.4 Revenue growth projections

13.5 Cost management strategies

13.6 Financial health indicators

13.7 Investment returns


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition targets

14.4 Strategic alliances

14.5 Supplier partnerships

14.6 Research collaborations

14.7 Community engagement


15. Execution Roadmap

15.1 Phase


Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of existing market reports and publications on carotid artery stents in Oman
  • Review of healthcare expenditure data and trends from the Ministry of Health in Oman
  • Examination of demographic and epidemiological studies related to cardiovascular diseases in the region

Primary Research

  • Interviews with interventional cardiologists and vascular surgeons practicing in Oman
  • Surveys conducted with hospital procurement managers regarding stent purchasing decisions
  • Focus group discussions with patients who have undergone carotid artery stenting procedures

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and secondary data sources
  • Triangulation of market size estimates using both top-down and bottom-up approaches
  • Sanity checks performed through consultations with healthcare policy experts and industry analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total addressable market based on national healthcare spending on cardiovascular treatments
  • Segmentation of the market by type of stents (bare-metal, drug-eluting) and patient demographics
  • Incorporation of government health initiatives aimed at reducing cardiovascular disease prevalence

Bottom-up Modeling

  • Collection of sales data from major medical device distributors in Oman
  • Estimation of average selling prices for different types of carotid artery stents
  • Volume estimates based on the number of procedures performed annually in hospitals

Forecasting & Scenario Analysis

  • Development of market forecasts using historical growth rates and projected healthcare trends
  • Scenario analysis based on potential changes in healthcare policies and technological advancements
  • Creation of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Cardiovascular Surgeons90Interventional Cardiologists, Vascular Surgeons
Hospital Procurement Managers80Procurement Officers, Supply Chain Managers
Patients with Carotid Artery Stents70Post-operative Patients, Caregivers
Healthcare Policy Experts40Health Economists, Policy Analysts
Medical Device Distributors60Sales Managers, Product Specialists

Frequently Asked Questions

What is the current value of the Oman Carotid Artery Stents Market?

The Oman Carotid Artery Stents Market is valued at approximately USD 7 million, reflecting a historical analysis and comparison with global market trends. This valuation highlights the growing demand for carotid artery stenting solutions in the region.

What factors are driving the growth of the Oman Carotid Artery Stents Market?

Which regions in Oman dominate the Carotid Artery Stents Market?

What types of carotid artery stents are available in Oman?

Other Regional/Country Reports

Indonesia Carotid Artery Stents Market

Malaysia Carotid Artery Stents Market

KSA Carotid Artery Stents Market

APAC Carotid Artery Stents Market

SEA Carotid Artery Stents Market

Vietnam Carotid Artery Stents Market

Other Adjacent Reports

Oman Vascular Stents Market

Malaysia Interventional Cardiology Devices Market

South Africa Stroke Prevention Devices Market

Germany Cardiovascular Implants Market

South Korea Endovascular Therapy Market

UAE Neurovascular Interventions Market

Bahrain Medical Imaging Equipment Market

Qatar Balloon Catheters Market

Qatar Drug-Eluting Stents Market

Global peripheral vascular devices market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022